Barbara A Powers

US Patent:

20030135196, Jul 17, 2003

Filed:

Aug 28, 2002

Appl. No.:

10/229619

Inventors:

David Hesson - Malvern PA, US
Glen Frazer - Wynnewood PA, US
Timothy Pelura - Malvern PA, US
Barbara Powers - Phoenixville PA, US
Bruce Shook - Devon PA, US

Assignee:

Neuron Therapeutics, Inc. - Malvern PA

International Classification:

A61M031/00

US Classification:

604/500000, 424/531000

Abstract:

Subarachnoid hemorrhage is treated by circulating a synthetic cerebrospinal fluid containing an emulsifying agent in the cerebrospinal fluid pathway in the vicinity of hemorrhage. The emulsifying agent scavenges blood products and circulation of the synthetic cerebrospinal fluid clears the blood products form the subarachnoid space to reduce cerebral vasospasm.

US Patent:

20130197081, Aug 1, 2013

Filed:

Jun 13, 2011

Appl. No.:

13/702747

Inventors:

Barbara L. Powers - Phoenixville PA, US
Vidal F. De La Cruz - Phoenixville PA, US
Steven Robertson - Motherwell, GB

Assignee:

FERRING B.V. - Hoofddorp

International Classification:

A61K 31/5575

US Classification:

514530

Abstract:

A method for decreasing likelihood of cesarean section delivery in a female in need thereof, comprises administering, intravaginally, to said female, misoprostol.

US Patent:

20150238414, Aug 27, 2015

Filed:

Jul 25, 2013

Appl. No.:

14/415946

Inventors:

- Hoofddorp, NL
Barbara L. Powers - Phoenixville PA, US

International Classification:

A61K 9/00
A61K 31/5575
A61K 38/11
A61K 47/34

Abstract:

A method of reducing the likelihood of infection requiring use of antibiotics during or after induction of labour in a female, comprises administering intravaginally to the female an insert comprising a cross-linked polyurethane reaction product of a polyethylene glycol, a triol and a diisocyanate, the insert containing 200 μg misoprostol; the likelihood of infection being reduced in comparison to the administration of said insert containing 10 mg dinoprostone.